Eylea 40mg Injection (Aflibercept) – Long Product Description

Eylea 40mg Injection (Aflibercept) is a prescription ophthalmic medicine manufactured by Bayer. It contains Aflibercept, a vascular endothelial growth factor (VEGF) inhibitor used to treat several serious retinal diseases that can lead to vision loss. Eylea helps preserve and improve vision by reducing abnormal blood vessel growth and fluid leakage in the retina. It is widely prescribed by ophthalmologists for conditions such as wet age-related macular degeneration (AMD), diabetic macular edema (DME), diabetic retinopathy (DR), macular edema following retinal vein occlusion (RVO), and myopic choroidal neovascularization (mCNV).

Each pack of Eylea 40mg Injection contains 1 vial for intravitreal injection (injection into the eye). The medicine must only be administered by a qualified ophthalmologist under sterile clinical conditions.

How Eylea 40mg Injection Works

Aflibercept is a recombinant fusion protein that acts as a VEGF trap. It binds to VEGF-A, VEGF-B, and Placental Growth Factor (PlGF), preventing these proteins from stimulating the formation of abnormal blood vessels and reducing leakage from existing retinal blood vessels.

By blocking these growth factors, Eylea helps:

• Reduce retinal swelling (macular edema).
• Prevent abnormal blood vessel growth.
• Improve or stabilize vision.
• Slow the progression of retinal diseases.

Its targeted mechanism makes Eylea one of the leading anti-VEGF therapies for retinal disorders.

Uses of Eylea 40mg Injection

Eylea 40mg Injection is indicated for the treatment of:

• Neovascular (Wet) Age-Related Macular Degeneration (AMD).
• Diabetic Macular Edema (DME).
• Diabetic Retinopathy (DR).
• Macular Edema following Retinal Vein Occlusion (Branch or Central RVO).
• Myopic Choroidal Neovascularization (mCNV).

Treatment frequency varies depending on the eye condition, treatment response, and recommendations of the treating ophthalmologist.

Benefits of Eylea 40mg Injection

Eylea offers several important clinical benefits, including:

• Helps improve or maintain vision in patients with retinal diseases.
• Reduces retinal swelling and fluid accumulation.
• Inhibits abnormal blood vessel formation.
• May slow the progression of vision-threatening eye diseases.
• Administered directly into the eye for targeted treatment.
• Manufactured by Bayer, a globally trusted pharmaceutical company.

Dosage and Administration

Eylea 40mg Injection should only be administered by an experienced ophthalmologist as an intravitreal injection.

The dosing schedule depends on the condition being treated:

• Wet AMD typically begins with monthly injections, followed by extended treatment intervals based on clinical response.
• DME, DR, RVO, and mCNV treatment schedules vary according to established clinical guidelines and the patient’s response.

Patients require regular eye examinations and retinal imaging during treatment to monitor disease activity and treatment effectiveness.

Possible Side Effects

Like all medicines, Eylea may cause side effects, although not everyone experiences them.

Common side effects include:

• Eye pain
• Redness of the eye
• Increased eye pressure
• Blurred vision immediately after injection
• Floaters
• Tearing
• Mild eye irritation

Serious side effects may include:

• Endophthalmitis (serious eye infection)
• Retinal detachment
• Cataract following injection
• Severe increase in intraocular pressure
• Intraocular inflammation
• Vision loss
• Stroke or arterial thromboembolic events (rare)

Patients should seek immediate medical attention if they experience severe eye pain, sudden vision loss, increasing redness, light sensitivity, or flashes of light.

Precautions and Warnings

Before receiving Eylea 40mg Injection, inform your ophthalmologist if you have:

• An active eye infection.
• Eye inflammation.
• Glaucoma or elevated eye pressure.
• Recent eye surgery.
• History of stroke or heart attack.
• Pregnancy or plans to become pregnant.
• Breastfeeding.

Eylea should not be administered in eyes with active ocular or periocular infections.

Storage Information

Store Eylea 40mg Injection in a refrigerator at 2°C to 8°C. Do not freeze. Keep the vial in its original carton to protect it from light until ready for use. The medicine should only be prepared and administered by trained healthcare professionals.

Why Buy Eylea 40mg Injection from MedicineWalyDost?

At MedicineWalyDost, we provide genuine imported ophthalmic and specialty medicines sourced from trusted manufacturers. Eylea 40mg Injection by Bayer is available with reliable nationwide delivery across Pakistan for hospitals, eye clinics, and patients requiring advanced retinal disease treatment.

When you order from MedicineWalyDost, you receive:

• Genuine imported ophthalmic medicines.
• Competitive prices.
• Nationwide delivery across Pakistan.
• Temperature-conscious packaging where required.
• Professional customer support.
• Assistance with medicine availability and ordering.

Note: A valid prescription from a qualified ophthalmologist is required before purchasing Eylea 40mg Injection.

---

Frequently Asked Questions (FAQs)

What is Eylea 40mg Injection used for?

Eylea is used to treat wet age-related macular degeneration (AMD), diabetic macular edema (DME), diabetic retinopathy (DR), retinal vein occlusion (RVO)-related macular edema, and myopic choroidal neovascularization (mCNV).

Who manufactures Eylea 40mg Injection?

Eylea 40mg Injection is manufactured by Bayer.

What does each pack contain?

Each pack contains 1 vial for intravitreal administration.

How is Eylea administered?

Eylea is administered as an intravitreal injection directly into the eye by a qualified ophthalmologist under sterile conditions.

Is a prescription required?

Yes. Eylea 40mg Injection is a prescription-only ophthalmic medicine and should only be administered under the supervision of a qualified eye specialist.